diallyl trisulfide has been researched along with Familial Nonmedullary Thyroid Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Cheng, X; Wang, X; Wang, Y; Wu, J; Wu, L; Xu, S; Yu, H; Zhang, L; Zheng, J | 1 |
| Bao, J; Cheng, X; Lu, R; Pan, J; Xu, S; Yu, H; Zhang, L | 1 |
2 other study(ies) available for diallyl trisulfide and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Diallyl trisulphide, a H
Topics: Allyl Compounds; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Phenotype; Proto-Oncogene Proteins c-akt; SOXB1 Transcription Factors; Sulfides; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2021 |
Induction of Apoptosis in Human Papillary-Thyroid-Carcinoma BCPAP Cells by Diallyl Trisulfide through Activation of the MAPK Signaling Pathway.
Topics: Allyl Compounds; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Garlic; Humans; Mitochondria; Mitogen-Activated Protein Kinases; Signal Transduction; Sulfides; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |